New federal rule cuts Medicaid funding for trans youth care starting Oct. 13
A final CMS rule bars federal Medicaid and CHIP dollars from paying for puberty blockers, hormones or surgery for minors. Here is what changes and who it touches.
What happened
On Aug. 11, 2026, the Centers for Medicare & Medicaid Services published a final rule that prohibits federal Medicaid and CHIP funds from covering gender-affirming care for people under 18, including puberty blockers, hormones and surgery. It takes effect Oct. 13, 2026.
The rule was first proposed in December 2025, alongside a declaration from HHS Secretary Robert F. Kennedy Jr. that such care for young people is not legitimate medicine. The administration says it is protecting children from treatments it considers unproven. Major medical groups, including the American Academy of Pediatrics, have supported access to this care, and advocates say the rule will cut off families who rely on public insurance.
What it means in the Southeast
Alabama, Georgia, Florida, Tennessee and most of the region already ban much of this care for minors under state law, so for many families here the practical change is small. The rule matters most for families who travel to another state for care, and it sets a national floor that states cannot fill with federal dollars. States could still choose to pay with their own money.
What you can do
- If your child is on Medicaid or CHIP and receives this care anywhere, call their clinic before Oct. 13 to ask about continuity and costs.
- The Campaign for Southern Equality offers navigation help for Southern families of trans youth.
- Parents looking for other families can find a PFLAG chapter or join PFLAG's free online group for parents of trans and nonbinary kids through PFLAG Connects.
- Legal challenges are likely. We will update this post if a court blocks the rule.